Category: Amicus

Amicus (NASDAQ:) Therapeutics, Inc. (NASDAQ:FOLD) President and CEO Bradley L. Campbell recently engaged in transactions involving the company’s common stock, according to a new filing with the Securities and Exchange Commission. On May 1, 2024, Campbell sold 7,500 shares of his stock Amicus Treatments With a weighted average price of…